Four Patients Complete Treatment in Phase 2 Trial of OXS-1550 as Lymphoma and Leukemia Treatment
News
Four lymphoma and leukemia patients have completed treatment with the cancer therapy OXS-1550 (DT2219ARL) in a Phase 2 clinical trial being run by GT Biopharma and the University of Minnesota. ... Read more